From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials.

Recent advances in next-generation sequencing and molecular profiling have significantly expanded our understanding of the tumor mutational landscape, leading to a substantial increase in the number of novel targeted agents. Small molecules have tran…

Preview only. Read the full abstract at the source